Shareholders of Fidson Healthcare Plc, Nigeria’s largest pharmaceutical company, have approved a dividend payment totaling ₦3.6 billion.
The decision was reached during the company’s 27th Annual General Meeting (AGM), which was held virtually on Thursday, 30 July 2026.
Details of the payout
The approved dividend is set at ₦1.50 per 50 kobo ordinary share. This financial distribution follows a year in which the company reported achieving several key milestones in its operations.
Strategic goals for African expansion
Alongside the dividend approval, Fidson Healthcare reaffirmed its long-term strategic path to become the largest pharmaceutical manufacturer in Africa.
The company’s ambition focuses on scaling its manufacturing capabilities to move beyond its current status as Nigeria’s leader in the sector and secure a dominant position across the continent.
The approval of the dividend reflects the company’s current financial position as it pursues this broader expansion strategy within the African healthcare market.
Explore more Companies stories and analysis from Business Elites Africa.
